Symplekin is a dual location protein that has been localized to the cytoplasmic plaques of tight junctions but also occurs in the form of interchromatin particles in the karyoplasm. Here we report the identification of two novel and major symplekin-containing protein complexes in both the karyo-and the cytoplasm of Xenopus laevis oocytes. Buffer-extractable fractions from the karyoplasm of stage IV-VI oocytes contain an 11S particle, prepared by immunoselection and sucrose gradient centrifugation, in which symplekin is associated with the subunits of the cleavage and polyadenylation specificity factor (CPSF). Moreover, in immunofluorescence microscopy nuclear symplekin colocalizes with protein CPSF-100 in the "Cajal bodies." However, symplekin is also found in cytoplasmic extracts of enucleated oocytes and egg extracts, where it occurs in 11S as well as in ca. 65S particles, again in association with CPSF-100. This suggests that, in X. laevis oocytes, symplekin is possibly involved in both processes, 3Ј-end processing of pre-mRNA in the nucleus and regulated polyadenylation in the cytoplasm. We discuss the possible occurrence of similar symplekin-containing particles involved in mRNA metabolism in the nucleus and cytoplasm of other kinds of cells, also in comparison with the nuclear forms of other dual location proteins in nuclei and cell junctions.
INTRODUCTIONCell biologists had recently to recognize, much to their surprise, that certain proteins appear, often in the same cells, as "dual location proteins," i.e., as general constituents of two rather distant and different structures: On the one hand, they occur as components of cytoskeletal plaques of a specific kind of intercellular junction, and on the other hand, they are located in karyoplasmic, interchromatinic granules, even in cells devoid of any junctions. Examples include the plakophilins PKP 1-3, typical of desmosomal plaques (Mertens et al., 1996;Schmidt et al., 1997Schmidt et al., , 1999Bonné et al., 1999), the adherens junction proteins, ARVCF (Borrmann, 2000;Borrmann et al., 2000; for cDNA transfection experiments see also Mariner et al., 2000), afadin (Mandai et al., 1997) and protein 4.1 (Krauss et al., 1997;Lallena et al., 1998), and the tight junction plaque proteins ZO-1 (Gottardi et al., 1996), symplekin (Keon et al., 1996), Ash-1 (Nakamura et al., 2000), and ZONAB (Balda and Matter, 2000). Obviously, this constitutively dual location at junctions and in nuclei has to be distinguished from observations of transient nuclear accumulations of certain other junctional plaque proteins in special stages of the cell cycle or differentiation or upon expression of certain transfected cDNAs or genes (for examples see, e.g., Funayama et al., 1995;Karnovsky and Klymkowsky, 1995;Behrens et al., 1996;Huber et al. 1996;Molenaar et al., 1996;Schneider et al., 1996;Yost et al., 1996;Daniel and Reynolds, 1999; for reviews see Behrens, 2000;Hü bner et al., 2001).Such a constitutively dual localization has also been reported in many diverse cultured cells and...